JB Chemicals & Pharmaceuticals Ltd.
NSE: JBCHEPHARM | BSE: 506943
₹2,408.90
₹-97.10
(-3.87%)
As on 16-Jul-2026IST
Market cap
₹38,731 Cr
Revenue (TTM)
₹4,148 Cr
P/E Ratio
54.6
P/B Ratio
9.3
Div. Yield
0.9 %
Quality Score
10/10
Growth Score
5/10
Valuation Score
3/10
Momentum Score
UNRATED/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹709 Cr
-
ROE
19.1 %
-
ROCE
25.2 %
-
Industry P/E
38.08
-
EV/EBITDA
33
-
Debt to Equity
0
-
Book Value
₹259
-
EPS
₹44.2
-
Face value
1
-
Shares outstanding
160,558,706
10 Years Aggregate
CFO
₹4,311.64 Cr
EBITDA
₹5,935.21 Cr
Net Profit
₹3,955.73 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
JB Chemicals
| 32.4 | 8.6 | 21.6 | 46.0 | 23.3 | 21.7 | 33.8 |
|
BSE Healthcare*
| 13.5 | 1.6 | 11.5 | 9.5 | 22.7 | 13.4 | 11.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
JB Chemicals
| -3.1 | 14.1 | 67.1 | 9.3 | 72.1 | 136.8 | 36.8 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
JB Chemicals
|
2,408.9 | 38,730.8 | 4,147.8 | 709.5 | 22.3 | 19.1 | 54.6 | 9.3 |
| 7,938.5 | 19,771.8 | 2,275.6 | 187.5 | 10.3 | 23 | 105.4 | 22.8 | |
| 2,495.8 | 19,070.6 | 2,187.2 | 649.7 | 31.5 | 19 | 29.7 | 5.3 | |
| 2,090.3 | 12,741.8 | 1,403.2 | 185.1 | -- | 27.4 | 68.8 | 17.1 | |
| 1,389.2 | 19,256.9 | 3,129.4 | 647.4 | 26.9 | 18.1 | 31.1 | 4.9 | |
| 4,586.8 | 20,996.8 | 2,519.7 | 722.4 | 33.6 | 17.2 | 29.1 | 5.0 | |
| 6,672.0 | 11,071.5 | 1,408.0 | 326.9 | 30.8 | 57.1 | 33.9 | 21.1 | |
| 3,403.5 | 7,839.9 | 1,773.8 | 309.8 | 24.0 | 43.1 | 25.3 | 10.1 | |
| 604.3 | 11,891.4 | 1,538.1 | 226.2 | 20.4 | 9 | 48.9 | 4.6 | |
| 1,020.8 | 9,475.4 | 4,858.7 | 574.5 | 14.9 | 20.3 | 17 | 3.0 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About JB Chemicals
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium,... diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, the company offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services. It provides its products to gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynaecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India. Read more
-
Incorporated
1976
-
Chairman
Arun Duggal
-
Managing Director
Aman Mehta
-
Headquarters
Ahmedabad, Gujarat
-
Website
Looking for more details about JB Chemicals & Pharmaceuticals Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for JB Chemicals
What is the current share price of JB Chemicals & Pharmaceuticals Ltd Today?
The share price of JB Chemicals & Pharmaceuticals Ltd is ₹2,408.90 (NSE) and ₹2,412.25 (BSE) as of 16-Jul-2026 IST. JB Chemicals & Pharmaceuticals Ltd has given a return of 23.32% in the last 3 years.
What is the current PB & PE ratio of JB Chemicals & Pharmaceuticals Ltd?
The P/E ratio of JB Chemicals & Pharmaceuticals Ltd is 54.59 times as on 16-Jul-2026, a 43 premium to its peers’ median range of 38.08 times.
The P/B ratio of JB Chemicals & Pharmaceuticals Ltd is 9.31 times as on 16-Jul-2026, a 77 premium to its peers’ median range of 5.27 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2026
|
46.69
|
7.96
|
|
2025
|
38.29
|
7.73
|
|
2024
|
46.32
|
9.20
|
|
2023
|
18.61
|
6.47
|
|
2022
|
31.59
|
5.88
|
What is the 52 Week High and Low of JB Chemicals & Pharmaceuticals Ltd?
The 52-week high and low of JB Chemicals & Pharmaceuticals Ltd are Rs 2,525.50 and Rs 1,638.50 as of 24-Jul-2026.
What is the market cap of JB Chemicals & Pharmaceuticals Ltd?
JB Chemicals & Pharmaceuticals Ltd has a market capitalisation of ₹ 38,731 Cr as on 16-Jul-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in JB Chemicals & Pharmaceuticals Ltd?
Before investing in JB Chemicals & Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.